Alzheimer’s disease is a debilitating neurodegenerative disease and the most common form of dementia. Symptoms include irritability, confusion, mood swings, language difficulties and memory loss. Cognitive dysfunction becomes more pronounced as the disease progresses, leading to the loss of bodily functions and eventually death.
Alzheimer’s disease is characterized by the presence of amyloid plaques in the brain. Soluble beta-amyloid (Abeta) oligomers are thought to underlie the cognitive deficits associated with Alzheimer’s disease. Cognition Therapeutics therapies pharmacologically compete with Abeta oligomers for critical receptor targets preventing synapse loss and improving memory and their small molecule therapeutics act through molecular targets that have not been previously implicated in Alzheimer’s disease.
Cognition Therapeutics has received a US patent that describes the discovery of several candidate drug molecules which can stop the effects of the brain protein that appears to play a major role in development of Alzheimer's disease. Disease-relevant screening technologyclosely models the pathology of neurodegenerative diseases and novel, high-quality CNS-biased chemical libraries. These platforms can predict behavioral efficacy of candidate drugs in Alzheimer's models. U.S. National Stage Application: No. 13/263,162, entitled "Inhibitors of Cognitive Decline" was filed on October 6, 2011.
CogRx CEO Hank Safferstein said, "The allowance of this patent demonstrates the strength of Cognition Therapeutics's intellectual property and high-level recognition that its technologies are both relevant and of great value to the therapy and ultimate conquering of Alzheimer's disease."
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Great Earthquakes Doubled In The Most Recent 10 Year Period - What That Means
- Why Climate 'Uncertainty' Is No Excuse For Doing Nothing
- What Americans Fear Most Isn't Ebola Or Terrorism, It's...
- Moderate Pot Use By Adolescents Doesn't Hurt IQ
- Cosmic Rays Jeopardize Deep-Space Astronaut Missions
- Slavery In America: Back In The Headlines
- HPV Vaccine Does Not Cause Multiple Sclerosis
- "Nah. It's not free for the iPhone/iPad/iPod Touch. Apple products usually don't play nice with..."
- "http://www.cdc.gov/vaccinesafety/vaccines/HPV/index.html says no interesting difference in side..."
- "Tommaso, I fully agree with you that for the moment it would be unwise and unjustified to committ..."
- "Chaos, thanks, I couldn't come up with the word. Well, sure. The article really didn't work to..."
- "So many decisions seem to be made by ISEBYs — in someone else’s back yard. ..."
- Anti-conventional ag movement spurs Big Ag to look to organic pesticides
- Can people really inherit memories?
- An end to fat shaming? The 50 year DNA mystery of metabolic dysfunction may soon be solved
- Egg freezing: a smart career move?
- Women carry fetal DNA long after children’s birth
- Despite resistance, China will dominate future of GMOs
- UNC scientists discover hidden subpopulation of melanoma cells
- Teenage self-harm linked to problems in later life
- Unsteady on your feet? Little touches could make all the difference
- Promising blood biomarkers identified for colorectal cancer: Is a screening blood test within reach?
- Studies must be carried out to determine whether exercise slows the onset of type 1 diabetes in children and adults